FIELD: medicine, pharmaceutics.
SUBSTANCE: invention relates to compounds of formula 1, where G represents a group (1) , where R9 represents an aryl, optionally substituted with C1-C3alkoxy or halogen; or (2) a substituded or non-substituted azole or pyrrole ring, condensed with a substituted or non-substituted aryl, heteroaryl, C5-C6cycloalkyl or heterocyclyl, or to its pharmaceutically acceptable salts, methods of its obtaining and application in the treatment of proliferative disorders, such as cancer.
EFFECT: obtaining the compounds for the treatment of proliferative disorders, such as cancer.
32 cl, 1 tbl, 91 ex
Title | Year | Author | Number |
---|---|---|---|
PROTEIN KINASE INHIBITORS | 2013 |
|
RU2678767C2 |
AMIDE DERIVATIVES AS GRP119 AGONISTS | 2014 |
|
RU2642429C2 |
PROTEIN KINASE INHIBITORS | 2013 |
|
RU2679122C2 |
COMPOUNDS BINDING BTR DOMAIN OF IAP PROTEINS | 2007 |
|
RU2472780C2 |
PYRROLO[2,1-A]ISOQUINOLINES | 2009 |
|
RU2495037C2 |
BICYCLIC HETEROCYCLES AS MEK KINASE INHIBITORS | 2009 |
|
RU2509078C2 |
MODULATORS CCR2 | 2016 |
|
RU2726206C2 |
NEW TETRAZOLE DERIVATIVES AND THEIR USE IN THE TREATMENT OF TUBERCULOSIS | 2018 |
|
RU2800930C2 |
HETEROBICYCLIC DERIVATIVES AS HCV INHIBITORS | 2012 |
|
RU2621734C1 |
NOVEL AMIDE DERIVATIVES OF PIPERIDINE CARBOXYLIC ACID | 2006 |
|
RU2410374C2 |
Authors
Dates
2015-11-10—Published
2011-02-11—Filed